Lilly Acquires 4E Therapeutics to Advance Non-Opioid Chronic Pain Pipeline

Eli Lilly and Company has acquired Austin-based biotechnology company 4E Therapeutics, adding a clinical-stage non-opioid pain program focused on chronic... Read More

The post Lilly Acquires 4E Therapeutics to Advance Non-Opioid Chronic Pain Pipeline appeared first on citybiz.